NLRP3 and myocardial ischemia: We propose a hypothesis that cardiomyocytes produce pyrolysis after myocardial ischemia reperfusion, and Sevoflurane reduces cellular inflammation and pyrolysis by inhibiting NLRP3 expression, which explains the anti-MIRI effect of Sevoflurane.